Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Hepatitis C Clinical Trials
Hepatitis C clinical trials are recruiting across 24 cities. Here are the cities with the most active studies:
Hepatitis C Trial Phases
10 research organizations are sponsoring hepatitis c trials.
About Hepatitis C
Hepatitis C is a viral infection that causes liver inflammation and can lead to serious liver damage. Direct-acting antiviral medications can now cure over 95% of chronic hepatitis C cases. Ongoing research focuses on increasing access to treatment and preventing reinfection.
Clinical trials are advancing new treatments for hepatitis c. Currently, 11 studies are recruiting a combined 2,566 participants across the United States. Research is being conducted by 10 organizations including University of California, San Francisco, Baylor Research Institute, University of Washington and 7 others.
2026 Hepatitis C Research Landscape
As of July 2026, the hepatitis c clinical trial landscape includes 11 actively recruiting studies across 24 cities in the United States. These studies are collectively seeking 2,566 participants, with an average enrollment target of 233 per study.
The research spans multiple phases of development: 6 studies are in NA, 1 study is in PHASE4, 1 study is in PHASE1, 1 study is in PHASE2. Early-phase studies suggest new therapeutic approaches are being explored for hepatitis c.
Research is being led by 10 different organizations, including University of California, San Francisco, Baylor Research Institute, University of Washington, H. Lee Moffitt Cancer Center and Research Institute, Johns Hopkins University, and 5 others.
Geographically, hepatitis c trials are most concentrated in Baltimore, Maryland (3 trials); San Francisco, California (1 trial); Dallas, Texas (1 trial); Seattle, Washington (1 trial); Tampa, Florida (1 trial) and 7 other cities.
Featured Hepatitis C Studies
Highlighted recruiting studies for hepatitis c, selected by enrollment size and research scope.
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treatment initiation among adult people who inject drugs (PWID).
The Hepatitis C Transplant Collaborative
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
The objective of this study is to extend our prior research by conducting a pragmatic implementation trial using a parallel-group, cluster randomized design to evaluate the PPP-CCM's ability to improve access to DAAs for HCV within a network of permanent supportive housing (PSH) buildings in Seattle and King County. The study will implement PPP-CCM to 16 housing buildings, randomizing half to rece...
Frequently Asked Questions About Hepatitis C Clinical Trials
Are there hepatitis c clinical trials near me?
Yes, there are 11 hepatitis c clinical trials currently recruiting across 24+ cities in the United States, including Baltimore, Maryland; San Francisco, California; Dallas, Texas. Browse the studies above to find one at a location convenient for you.
How do I join a hepatitis c clinical trial?
To join a hepatitis c clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are hepatitis c clinical trials free?
Yes, participation in hepatitis c clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of hepatitis c treatments are being studied?
Current hepatitis c clinical trials are testing a range of approaches across NA (6 studies), PHASE4 (1 study), PHASE1 (1 study), PHASE2 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 10 research organizations.
Is it safe to participate in hepatitis c clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov